Erschienen in:
11.10.2016 | Letter to the Editor
Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism
verfasst von:
Radwan Kassir, Jean Gugenheim, Tarek Debs, Imed Ben Amor, Olivier TIffet
Erschienen in:
Obesity Surgery
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Excerpt
The EndoBarrier®, also known as a duodenal-jejunal bypass sleeve or a gastrointestinal liner, is a single-use 60-cm impermeable fluoropolymer sleeve that is placed endoscopically via the mouth and anchored in the first part of the small bowel (duodenum) in a procedure that takes around 30 min. EndoBarrier® receives the contents of the stomach and acts to reduce the uptake of nutrients and calories from the first part of the small bowel (the duodenum and the first section of the jejunum). EndoBarrier® is the first endoscopically delivered device for people living with uncontrolled type 2 diabetes (T2DM) and obesity. …